Copyright
©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 107255
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.107255
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.107255
Table 3 Perioperative clinical data, n (%)
Salvage operation | Patients (n = 28) |
Type of surgery | |
Laparoscopy | 7 (25.0) |
Open | 21 (75.0) |
Operative time, median (IQR), minutes | 245 (182.5-370.0) |
Intraoperative blood loss, median (IQR), mL | 200 (100.0-475.0) |
Intraoperative blood transfusion | |
Yes | 13 (46.4) |
No | 15 (53.6) |
Pathological reaction | |
PCR | 14 (50.0) |
Non-PCR | 14 (50.0) |
Post-operative hospitalization days, median (IQR), days | 16 (7.5-23.8) |
Post-operative complication | |
Present | 20 (71.4) |
Absent | 8 (28.6) |
Clavien-Dindo class | |
I-II | 16 (57.1) |
III-V | 4 (14.3) |
Post-operative complication | |
Liver failure | 6 (21.4) |
Abdominal fluid | 13 (46.4) |
Bile leakage | 4 (14.3) |
Abdominal infection | 7 (25.0) |
Abdominal hemorrhage | 1 (3.6) |
Pleural effusion | 15 (53.6) |
- Citation: Zhang SB, Nashan B, Wang YL, Zhang SG. Efficacy of salvage surgery for hepatocellular carcinoma following conversion therapy. World J Clin Oncol 2025; 16(6): 107255
- URL: https://www.wjgnet.com/2218-4333/full/v16/i6/107255.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i6.107255